VC Catalog · venture ecosystem research library
VC Catalog home Beta

Company

LYNK Pharmaceuticals

Rocket Ship RatingBased on the data VC Catalog holds.

Rocket Ship Rating: 77 out of 100

Innovative & Differentiated Therapies for Global Patients

  • Biotech & therapeutics
Status
Operatingas of 2026-09-17
Business model
B2B
Headquarters
Hangzhou, China
Founded
2018
Claim, correct or request removal

Record updated 28 September 2026

About

Lynk Pharmaceuticals is a clinical-stage innovative drug company focused on autoimmune and inflammatory diseases, committed to addressing unmet clinical needs through first-in-class innovation, developing differentiated small-molecule therapies, and providing superior oral alternatives to biologics.

Products

Other
LNK01001
Other
LNK01004
Loading relationship preview

Cookies on VC Catalog

We use necessary cookies to run the site (sign-in, security, remembering this choice). With your permission we also use Google Analytics to understand how the site is used. Analytics cookies are set only if you accept all cookies. Privacy policy